Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031). 1983

H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson

The pharmacokinetics of chlorambucil has been investigated in a cross over study after oral administration of the free drug (10 mg) and its prednisolone ester (prednimustine, 100 mg). The bioavailability of chlorambucil was about five times lower when given as prednimustine as compared to administration of the free drug. The peak plasma concentration was about twice as high and it was obtained more rapidly when the free drug was given. No intact prednimustine could be detected in plasma.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011238 Prednimustine Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity. Leo-1031,NSC-134087,Sterecyt,Stereocyt,Stéréocyt,Leo 1031,Leo1031,NSC 134087,NSC134087
D002699 Chlorambucil A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid,Amboclorin,CB-1348,Chloraminophene,Chlorbutin,Leukeran,Lympholysin,N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid,NSC-3088,CB 1348,CB1348,NSC 3088,NSC3088
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
November 1983, Cancer,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
January 1991, Oncology,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
January 1975, Journal of surgical oncology,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
February 1983, British journal of clinical pharmacology,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
January 1977, Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
August 1977, European journal of cancer,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
January 1977, European journal of cancer,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
March 1979, Cancer treatment reports,
H Ehrsson, and I Wallin, and S O Nilsson, and B Johansson
January 1985, Archiv fur Geschwulstforschung,
Copied contents to your clipboard!